Highlights

Visit Sweet group webpage

Professor Matt Sweet uses techniques in immunology, cell biology and biochemistry to understand how the innate immune system functions in health and disease. His research focuses on characterizing genes and pathways in macrophages that either drive inflammation or are involved in the clearance of bacterial pathogens. The ultimate aim of his research is to devise strategies to manipulate the innate immune system to limit pathological inflammation and/or unleash its power against infections caused by antibiotic-resistant bacteria.

During his career, he has discovered mechanisms by which specific pathogen products activate macrophages; identified regulatory mechanisms controlling innate immune activation and inflammation; defined roles for histone deacetylase enzymes in infection and inflammation; elucidated antimicrobial responses used by macrophages to destroy bacteria, as well as mechanisms used by bacterial pathogens such as Salmonella and uropathogenic E. coli to subvert these responses; and identified molecular mechanisms by which immune cells use immunometabolism to drive inflammation and combat infections.

Professor Matt Sweet completed his PhD in 1996 at The University of Queensland, and then undertook a CJ Martin postdoctoral training fellowship at the University of Glasgow, before returning to Australia. He is currently an NHMRC Leadership Fellow at the Institute for Molecular Bioscience. He has authored >170 journal articles and book chapters, including publications in Science (x2), Science Immunology, Science Translational Medicine, Nature Immunology, Nature Genetics, Nature Communications (x3), Journal of Experimental Medicine (x2) and PNAS (x5). Professor Sweet currently serves on the editorial boards of several international journals including Journal of Leukocyte Biology and Seminars in Cell and Developmental Biology.

Professor Sweet has served as the Director of Training for IMB since 2021, overseeing PhD and Masters student recruitment and training. He has a strong focus on research culture and on delivering excellence in HDR student training and development. Professor Sweet has supervised/co-supervised more than 35 PhD students and more than 20 Honours students, and his former students have leading roles in Academia, Industry, and Government. He has won inaugural prizes from the Society for Leukocyte Biology (2021) and IMB (2016) for mentorship and leadership. 

Connect

ResearcherIDScopusOrcid

 

Researcher biography

Matt Sweet is an NHMRC Leadership Fellow, Group Leader, and Director of Higher Degree Research (DHDR) at the Institute for Molecular Bioscience (IMB) at The University of Queensland, Brisbane, Australia. He was the founding Director of the IMB Centre for Inflammation and Disease Research (2014-2018), also serving as Deputy Head of the IMB Division of Cell Biology and Molecular Medicine during this period. Matt studies innate immunity, the body's danger sensing system that responds to infection, injury and dysregulated homeostasis, and the role of this system in health and disease. Matt's research team focuses on manipulating the innate immune system for the development of anti-infective and anti-inflammatory strategies. To do so, his lab characterizes the roles of specific innate immune pattern recognition receptors and their downstream signalling pathways/gene products in inflammatory disease processes, as well as in host responses to bacterial pathogens. He has authored >170 journal articles and book chapters, including in Science (2), Science Translational Medicine, Science Immunology, Nature Immunology, Nature Genetics, Nature Communications(3), PNAS USA (5) and Journal of Experimental Medicine (2), and his career publications have accrued >17,000 citations.

Biography

I was awarded a PhD (The University of Queensland) in 1996 for my research under the supervision of Prof David Hume into gene regulation in macrophages, immune cells with important roles in health and disease. I subsequently undertook a short postdoctoral position in the same laboratory, focusing on the activation of macrophages by pathogen products. I then embarked on a CJ Martin post-doctoral training fellowship with Prof Eddy Liew, FRS at the University of Glasgow in Scotland. Returning to The University of Queensland, I had a prominent role within the Cooperative Research Centre for Chronic Inflammatory Diseases (including as UQ node head from 2007-2008) and was appointed as a Group Leader at the IMB in 2007. I have continued fellowship support since this time, including as an ARC Future Fellow, an NHMRC Senior Research Fellow and an NHMRC Leadership Fellow (current, from 2021).

Key discoveries

CpG-containing DNA as an activator of innate immunity, and characterization of the receptor (TLR9) detecting this microbial component.

The IL-1 receptor family member ST2 as a critical regulator of innate immunity and inflammation.

Inflammatory and antimicrobial functions of histone deacetylase enzymes (HDACs) in macrophages.

Effects of the growth factor CSF-1 on inflammatory responses in macrophages.

Mechanisms responsible for divergence in TLR responses between human and mouse macrophages, as well as the functional consequences of such divergence.

TLR-inducible zinc toxicity as an antimicrobial weapon of macrophages.

Host evasion strategies used by the bacterial pathogens Salmonella enterica serovar Typhimurium and uropathogenic E. coli.

SCIMP as a novel TLR adaptor that mediates TLR tyrosine phosphorylation and selective cytokine outputs.

Genes and pathways associated with the severity of chronic liver disease.

Molecular mechanisms controlling macrophage immunometabolism, as well as associated inflammatory and antimicrobial responses.

Research training

I have supervised or co-supervised 25 completed PhD students and 22 completed honours students, as well as 9 post-doctoral researchers. Many of my former staff and students continue to have active research careers around the world (USA, UK, Europe, Australia), including as independent laboratory heads. I currently supervise 6 PhD students in my laboratory, co-supervise 6 PhD students in other laboratories, and oversee the research activities of 3 post-doctoral researchers in my group. Current and former staff/students have received numerous fellowships and awards during their research careers (e.g. ARC DECRA, NHMRC CJ Martin fellowship, UQ post-doctoral fellowship, Smart State scholarship). I have also examined >25 PhD theses in the fields of innate immunity, inflammation and host defence.

Professional activities

I am an editorial board member of the Journal of Leukocyte Biology, Immunology and Cell Biology, Seminars in Cell & Developmental Biology, and Frontiers in Immunology. I have served on NHMRC project grant review panels in 2007, 2008, 2009, 2012 (as panel chair) and 2014, an NHMRC Ideas panel in 2020, NHMRC Investigator panels in 2021 and 2022, as well as a member of the NHMRC RGMS user reference group committee from 2010-2012. I acted as national representative for the Australasian Society of Immunology (ASI) Infection and Immunity special interest group from 2012-2017. At UQ, I served as chair of an animal ethics committee from 2013-2014, and co-organized the UQ Host-Pathogen interaction network from 2007-2010 (prior to the establishment of the Australian Infectious Diseases Research Centre). I am currently Director of Higher Degree by Research at IMB, overseeing HDR student recruitment and training.

I have made extensive contributions to conference organization in my discipline. I co-organized the national TLROZ2009 and TLROZ2012 conferences, I organized the first ever Australasian Society for Immunology (ASI) Infection and Immunity workshop (2009), was chair of the ASI Program Committee and co-organizer of the Infection and Immunity workshop for ASI2017, and I co-organized the annual IMB Inflammation Symposium (2014-2018). I also co-chaired the 2019 World Conference of Inflammation (Sydney, September 2019). In addition, I have been a member of the organizing committee for ASI2009, the 2014 International Cytokine and Interferon Society conference, the Lorne Infection and Immunity conference (2014-2020), and the Brisbane Immunology Group annual meeting (2008 to the present).

Featured projects Duration
Innate immunity, infection and inflammation